Olema Oncology Inc Ordinary Shares (OLMA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$7.50

Buy

$7.94

arrow-up$0.04 (+0.53%)

Prices updated at 14 Nov 2026, 00:37 EST

Prices minimum 15 mins delay

Prices in USD

Olema Oncology Inc is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. Olema is advancing a pipeline of novel therapies by leveraging it ...

NASDAQ

-0.91%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$7.86 - $7.18
	$36.26 - $6.24
	-
	660.55m
	-
	-
	1,696,716
	1.79
	2,006,674.29
	0.75
	81.38m
	US68062P1066
	-1.87
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.